Skip to main content
SpringerLink
Log in

Oseltamivir

Acute intermittent porphyria recurrence: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Amador AP, et al. Acute intermittent porphyria: is oseltamivir safe in these patients?. Clinical Medicine (London, England) 22: 280-281, No. 3, May 2022. Available from: URL: http://doi.org/10.7861/clinmed.2022-0100

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oseltamivir. Reactions Weekly 1910, 380 (2022). https://doi.org/10.1007/s40278-022-17215-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-17215-0

Search

Navigation